Consuming vitamin D supplements may cut the risk of acquiring pancreatic cancer by nearly half according to a recent study led by researchers from Harvard and Northwestern universities in the US.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
The findings, appearing in the journal Cancer Epidemiology Biomarkers & Prevention, come from the first known study to use large-scale epidemiological surveys (researchers analysed two large, long-term health surveys) to examine the relationship between the nutrient and pancreatic cancer.
The study found that taking the US Recommended Daily Allowance of Vitamin D (400 IU/day) reduced the risk of pancreatic cancer by 43%. Those who consumed less than 150 IUs per day experienced a 22% reduced risk of cancer. Increased consumption of the vitamin beyond 400 IUs per day resulted in no significant increased benefit.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalData
Study leader Dr Halcyon Skinner said: “Because there is no effective screening for pancreatic cancer, identifying controllable risk factors for the disease is essential for developing strategies that can prevent cancer.”
